Cercare Medical, an Aarhus, Denmark-based chief in perfusion software program for stroke and neurodegenerative ailments, raised €7.4m (£6.17m GBP / $7.77m USD) in its newest funding spherical.
The spherical was led by UK-based West Hill Capital.
This funding will probably be used to broaden operations in key markets, with a give attention to the USA, the UK, and chosen European international locations.
Led by Jeppe Øvlesen, Chairman, and Kim Mouridsen, CEO, Cercare Medical has developed a software program (CMN) platform that gives superior perfusion maps for each CT and MRI imaging, equipping clinicians with a complete device to evaluate mind tissue pathologies.
Cercare Medical is a supplier of superior perfusion imaging options. With absolutely automated and multi-vendor suitable software program for CT and MRI perfusion imaging post-processing, they’re dedicated to delivering expertise that enhances affected person care and advances medical diagnostics throughout numerous neurological circumstances, together with Stroke, Oncology, Alzheimer’s, Dementia, and COVID-19. Its proprietary biomarkers enable for higher, extra exact imaging maps, bettering decision-making in vital care and enhancing neuroimaging.
Over latest years, the corporate has achieved yearly triple-digit development and has been adopted by outstanding stroke and oncology amenities in additional than 23 international locations. As a part of its growth technique, Cercare Medical is deepening its collaborations with key business companions, together with Microsoft, Siemens, Blackford, Aidoc, SECTRA, TeraRecon, and Viz.AI.
FinSMEs
05/03/2025
